Cargando…

Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)

BACKGROUND: The classic model of estrogen action requires that the estrogen receptor (ER) activates gene expression by binding directly or indirectly to DNA. Recent studies, however, strongly suggest that ER can act through nongenomic signal transduction pathways and may be mediated by a membrane bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Taguchi, Yasuto, Koslowski, Mirek, Bodenner, Donald L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516042/
https://www.ncbi.nlm.nih.gov/pubmed/15318942
http://dx.doi.org/10.1186/1478-1336-2-5
_version_ 1782121760627359744
author Taguchi, Yasuto
Koslowski, Mirek
Bodenner, Donald L
author_facet Taguchi, Yasuto
Koslowski, Mirek
Bodenner, Donald L
author_sort Taguchi, Yasuto
collection PubMed
description BACKGROUND: The classic model of estrogen action requires that the estrogen receptor (ER) activates gene expression by binding directly or indirectly to DNA. Recent studies, however, strongly suggest that ER can act through nongenomic signal transduction pathways and may be mediated by a membrane bound form of the ER. Estradiol covalently linked to membrane impermeable BSA (E(2)-BSA) has been widely used as an agent to study these novel membrane-associated ER events. However, a recent report suggests that E(2)-BSA does not compete for E(2 )binding to purified ER in vitro. To resolve this apparent discrepancy, we performed competition studies examining the binding of E(2 )and E(2)-BSA to both purified ER preparations and ER within intact cells. To eliminate potential artifacts due to contamination of commercially available E(2)-BSA preparations with unconjugated E(2 )(usually between 3–5%), the latter was carefully removed by ultrafiltration. RESULTS: As previously reported, a 10-to 1000-fold molar excess of E(2)-BSA was unable to compete with (3)H-E(2 )binding to ER when added simultaneously. However, when ER was pre-incubated with the same concentrations of E(2)-BSA, the binding of (3)H-E(2 )was significantly reduced. E(2)-BSA binding to a putative membrane-associated ER was directly visualized using fluorescein labeled E(2)-BSA (E(2)-BSA-FITC). Staining was restricted to the cell membrane when E(2)-BSA-FITC was incubated with stable transfectants of the murine ERα within ER-negative HeLa cells and with MC7 cells that endogenously produce ERα. This staining appeared highly specific since it was competed by pre-incubation with E(2 )in a dose dependent manner and with the competitor ICI-182,780. CONCLUSIONS: These results demonstrate that E(2)-BSA does bind to purified ER in vitro and to ER in intact cells. It seems likely that the size and structure of E(2)-BSA requires more energy for it to bind to the ER and consequently binds more slowly than E(2). More importantly, these findings demonstrate that in intact cells that express ER, E(2)-BSA binding is localized to the cell membrane, strongly suggesting a membrane bound form of the ER.
format Text
id pubmed-516042
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5160422004-09-05 Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA) Taguchi, Yasuto Koslowski, Mirek Bodenner, Donald L Nucl Recept Research BACKGROUND: The classic model of estrogen action requires that the estrogen receptor (ER) activates gene expression by binding directly or indirectly to DNA. Recent studies, however, strongly suggest that ER can act through nongenomic signal transduction pathways and may be mediated by a membrane bound form of the ER. Estradiol covalently linked to membrane impermeable BSA (E(2)-BSA) has been widely used as an agent to study these novel membrane-associated ER events. However, a recent report suggests that E(2)-BSA does not compete for E(2 )binding to purified ER in vitro. To resolve this apparent discrepancy, we performed competition studies examining the binding of E(2 )and E(2)-BSA to both purified ER preparations and ER within intact cells. To eliminate potential artifacts due to contamination of commercially available E(2)-BSA preparations with unconjugated E(2 )(usually between 3–5%), the latter was carefully removed by ultrafiltration. RESULTS: As previously reported, a 10-to 1000-fold molar excess of E(2)-BSA was unable to compete with (3)H-E(2 )binding to ER when added simultaneously. However, when ER was pre-incubated with the same concentrations of E(2)-BSA, the binding of (3)H-E(2 )was significantly reduced. E(2)-BSA binding to a putative membrane-associated ER was directly visualized using fluorescein labeled E(2)-BSA (E(2)-BSA-FITC). Staining was restricted to the cell membrane when E(2)-BSA-FITC was incubated with stable transfectants of the murine ERα within ER-negative HeLa cells and with MC7 cells that endogenously produce ERα. This staining appeared highly specific since it was competed by pre-incubation with E(2 )in a dose dependent manner and with the competitor ICI-182,780. CONCLUSIONS: These results demonstrate that E(2)-BSA does bind to purified ER in vitro and to ER in intact cells. It seems likely that the size and structure of E(2)-BSA requires more energy for it to bind to the ER and consequently binds more slowly than E(2). More importantly, these findings demonstrate that in intact cells that express ER, E(2)-BSA binding is localized to the cell membrane, strongly suggesting a membrane bound form of the ER. BioMed Central 2004-08-19 /pmc/articles/PMC516042/ /pubmed/15318942 http://dx.doi.org/10.1186/1478-1336-2-5 Text en Copyright © 2004 Taguchi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Taguchi, Yasuto
Koslowski, Mirek
Bodenner, Donald L
Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
title Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
title_full Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
title_fullStr Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
title_full_unstemmed Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
title_short Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA)
title_sort binding of estrogen receptor with estrogen conjugated to bovine serum albumin (bsa)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516042/
https://www.ncbi.nlm.nih.gov/pubmed/15318942
http://dx.doi.org/10.1186/1478-1336-2-5
work_keys_str_mv AT taguchiyasuto bindingofestrogenreceptorwithestrogenconjugatedtobovineserumalbuminbsa
AT koslowskimirek bindingofestrogenreceptorwithestrogenconjugatedtobovineserumalbuminbsa
AT bodennerdonaldl bindingofestrogenreceptorwithestrogenconjugatedtobovineserumalbuminbsa